Intermittent Inhibition of BRAF plus MEK Is Not Beneficial in Melanoma.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2020-152
Abstract: Compared with standard continuous dosing, intermittent dosing did not improve patient outcomes. read more here.
Keywords: beneficial melanoma; plus mek; intermittent inhibition; braf plus ... See more keywords